FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

14705011000001102: Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51629001000001119 Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
51629101000001118 Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Is a Tetrabenazine 12.5mg tablets true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has active ingredient Tetrabenazine true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has specific active ingredient Tetrabenazine true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) 112 tablet Is pack of False Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Inferred relationship Existential restriction modifier
Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) 112 tablet Has AMP True Tetrabenazine 12.5mg tablets (Cambridge Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start